REG - Zinnwald Lithium PLC - Appointment of Non-Executive Director

Zinnwald LithiumAnnouncement

25/04/2023 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230425:nRSY2277Xa&default-theme=true

RNS Number : 2277X  Zinnwald Lithium PLC  25 April 2023

Zinnwald Lithium plc / EPIC: ZNWD.L / Market: AIM / Sector: Mining

25 April 2023

Zinnwald Lithium plc

("Zinnwald Lithium" or the "Company")

 

Appointment of Non-Executive Director

 

Zinnwald Lithium plc, the German focused lithium development company, is
pleased to announce the appointment of Dr. Stefan Scherer as a Non-Executive
Director in accordance with the terms of the Relationship Agreement with AMG
Advanced Metallurgical Group N.V. ("AMG") announced on 22 March 2023.

 

As Chief Executive Officer of AMG Lithium GmbH and Chief Commercial Officer of
AMG Lithium BV, Dr. Scherer is responsible for AMG's downstream Lithium
business as well as the overall strategy development for its entire Lithium
operations.  After his studies in chemistry at the Technische Hochschule
Darnstadt, Dr. Scherer completed his PhD in Organic Chemistry at the Goethe
University in Frankfurt in 1995.  He has more than 20 years' experience in
the speciality and fine chemical industries in various R&D, operational
and management positions, including periods with Albermarle and Rockwood
Lithium/Chemetall, prior to joining AMG in 2019. Dr. Scherer is a German
citizen.

 

Zinnwald Lithium CEO, Anton du Plessis, said: "We are delighted to welcome Dr.
Stefan Scherer to the Board.  He brings significant lithium industry
experience that will be extremely relevant to our advanced integrated lithium
hydroxide project located in Saxony and a wealth of contacts within the German
business community, which will be invaluable as we move forward."

 

Disclosures under Schedule 2 of the AIM Rules

Dr. Scherer, aged 55, holds or has held the following directorships and/or
partnerships in the previous five years.

 

 Present Directorships / Partnerships  Past Directorships / Partnerships
 AMG Lithium GmbH (Germany)            Albermarle Germany GmbH

 AMG Lithium B.V. (Netherlands)

 

Dr. Scherer does not directly hold any shares nor options over ordinary shares
in the Company.  He is the appointed representative of AMG, which owns 25.1%
of the Company.

 

There is no further information which is required to be disclosed under
Schedule Two, paragraph (g) of the AIM Rules for Companies in respect of Dr.
Scherer.

 

*ENDS*

 

 For further information visit www.zinnwaldlithium.com or contact:

 

 Anton du Plessis       Zinnwald Lithium plc  info@zinnwaldlithium.com

 Cherif Rifaat
 David Hart             Allenby Capital       +44 (0) 20 3328 5656

 Dan Dearden-Williams   (Nominated Adviser)
 Michael Seabrook       Oberon Capital Ltd    +44 (0) 20 3179 5300

 Adam Pollock           (Joint Broker)
 Richard Greenfield     Tamesis Partner LLP   +44 (0) 20 3882 2868

 Charles Bendon         (Joint Broker)
 Isabel de Salis        St Brides Partners    zinnwald@stbridespartners.co.uk (mailto:zinnwald@stbridespartners.co.uk)

 Paul Dulieu            (Financial PR)

 

Notes

AIM quoted Zinnwald Lithium plc (EPIC: ZNWD.L) is focussed on becoming an
important supplier of lithium hydroxide to Europe's fast-growing battery
sector. The Company owns 100% of the Zinnwald Lithium Project in Germany,
which has an approved mining licence, is located in the heart of Europe's
chemical and automotive industries and has the potential to be one of Europe's
more advanced battery grade lithium projects.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAPPUUGCUPWUBC